Cargando…
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
Podoplanin/Aggrus, known as a platelet aggregation-inducing factor, is frequently overexpressed in lung squamous cell carcinomas (LSCC) and glioblastomas among other tumours, and its expression has been reported to be correlated with poor prognosis. However, the contribution of podoplanin to maligna...
Autores principales: | Miyata, Kenichi, Takemoto, Ai, Okumura, Sakae, Nishio, Makoto, Fujita, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481446/ https://www.ncbi.nlm.nih.gov/pubmed/28642617 http://dx.doi.org/10.1038/s41598-017-04324-1 |
Ejemplares similares
-
Platelet-activating factor podoplanin: from discovery to drug development
por: Takemoto, Ai, et al.
Publicado: (2017) -
A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis
por: Takemoto, Ai, et al.
Publicado: (2017) -
Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment
por: Miyata, Kenichi, et al.
Publicado: (2014) -
Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis
por: Sekiguchi, Takaya, et al.
Publicado: (2015) -
A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis)
por: Ukaji, Takao, et al.
Publicado: (2018)